Revision Laryngeal Surgery for the Suboptimal Injection of Calcium Hydroxylapatite
Revision Laryngeal Surgery for the Suboptimal Injection of Calcium Hydroxylapatite
复制标题
DOI：
10.1097/mlg.0b013e318184e6ee
复制
发表时间：
2008-12-01
期刊：
影响因子：
2.6
通讯作者：
Postma, Gregory N.
中科院分区：
文献类型：
--
作者：
Chheda, Neil N.;Rosen, Clark A.;Postma, Gregory N.
目的：本研究的目的是描述在隆喉术中羟基磷灰石钙注射不理想的管理。研究设计：在四个声音和吞咽中心进行回顾性分析，以确定在隆喉术中羟基磷灰石钙注射不理想的患者。结果：5名患者（年龄19-75岁）被确定为继发于浅表注射羟基磷灰石钙或真声带过度内侧化的声音受损。所有患者均接受了翻修手术，所有经历的主观和客观improvement.Conclusion：微皮瓣切除后，次优的羟基磷灰石钙注射成功返回的振动功能。完全控制初始注射对于避免这种并发症至关重要。
Objective: The objective of this study was to describe the management of suboptimal injection of calcium hydroxylapatite during augmentation laryngoplasty.Study Design: A retrospective review was conducted at four Voice and Swallowing centers to identify patients who had a suboptimal injection of calcium hydroxylapatite during augmentation laryngoplasty.Results: Five patients (ages 19-75) were identified with an impaired voice secondary to a superficial injection of calcium hydroxylapatite or over-medialization of the true vocal fold. All patients underwent revision surgery with all experiencing subjective and objective improvement.Conclusion: Microflap excision can lead to successful return of vibratory function after a suboptimal injection of calcium hydroxylapatite. Complete control of the initial injection is paramount to avoiding this complication.